Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Journal of Medicinal Chemistry|October 4, 2011
Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent α4β2 nicotinic acetylcholine receptor ligandsMarc J C Scanio, Lei Shi, William H Bunnelle, et al.The Journal of Pharmacology and Experimental Therapeutics|May 28, 2010
In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's diseaseR Scott Bitner, William H Bunnelle, Michael W Decker, et al.British Journal of Pharmacology|October 23, 2009
Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptorsClark A Briggs, Jens Halvard Grønlien, Peter Curzon, et al.Journal of Medicinal Chemistry|November 2, 2007
Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Michael E Brune, Steven A Buckner, et al.Journal of Cardiovascular Pharmacology|July 27, 2005
Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogsRyan M Fryer, Pamela A Rakestraw, Lee C Preusser, et al.Pain|June 20, 2006
(L)-Phenylglycine, but not necessarily other alpha2delta subunit voltage-gated calcium channel ligands, attenuates neuropathic pain in ratsJames J Lynch, Prisca Honore, David J Anderson, et al.Frontiers in Genetics|November 1, 2012
AhR activation underlies the CYP1A autoinduction by A-998679 in ratsMichael J Liguori, Chih-Hung Lee, Hong Liu, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Structure-activity relationship of a novel class of naphthyl amide KATP channel openersSean C Turner, William A Carroll, Tammie K White, et al.European Journal of Pharmacology|June 12, 2016
A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injuryChang Z Zhu, Sujatha Gopalakrishnan, Kelly Doyle, et al.Journal of Neuroscience Methods|July 5, 2011
KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channelsDi Zhang, Rama Thimmapaya, Xu-Feng Zhang, et al.Pageof 11